ECHO is rapidly expanding in Africa, Asia, and Latin America in addressing the major global health issues of HIV and Tuberculosis (TB) as well as supporting quality improvement in HIV testing and laboratory science. The Global HIV ECHO Initiative in collaboration with the US Centers for Disease Control and Prevention (CDC) and other partners aims to improve care and treatment for people living with HIV (PLHIV). The initiative focuses on high burden countries supported through the President’s Emergency Plan for AIDS Relief (PEPFAR). The ECHO model is used to help countries reach PEPFAR’s 90-90-90 goals to gain epidemic control: By 2020, 90% of all people living with HIV will know their HIV status; 90% of all people with diagnosed HIV infection will receive sustained antiretroviral therapy; 90% of all people receiving antiretroviral therapy will have viral suppression. HIV is a manageable disease requiring treatment through antiretroviral therapy and despite significant progress is still considered a major global health issue:
 
  • 36.9 million people globally were living with HIV (end 2014)
  • 2 million people became newly infected with HIV (end 2014)
  • 15.8 million people accessing antiretroviral therapy (June 2015)
  • 1.2 million people died from AIDS-related illnesses (end 2014)
  • 25.3 million people have died of AIDS-related diseases since 2000
Source: http://www.cdc.gov/globalhivtb/index.html
Map, Adult HIV Prevalence Rate 2014
TB is a preventable, treatable, and curable infectious disease. Yet, TB ranks alongside HIV as the leading cause of death from infectious diseases worldwide.
  • One third of the world’s population – 2 billion people – is infected with TB.
  • In 2014, 9.6 million people around the world became sick with TB disease, and there were 1.5 million TB-related deaths worldwide.
  • TB is the leading cause of death of people who are HIV infected.
Source: http://www.cdc.gov/tb/statistics/default.htm  

Countries in various stages of implementing HIV, TB and Lab ECHO programs under this initiative

 
AFRICA
  • HIV: Namibia (launched Fall 2015), Kenya (launched September 2016), Botswana, Cameroon, Cote d’Ivoire, Malawi
  • Lab (HIV rapid testing): Tanzania (Launched November 2016), Uganda (March 2017), South Africa, Kenya
  • TB: Kenya (launched July 2016)

Partners

  • University of Maryland, ICAP at Columbia University,
  • Elizabeth Glaser Pediatric AIDS Foundation (EGPAF),
  • International Training and Education Center for Health (I-TECH) at the University of Washington
  • CDC headquarters and country offices, and other local and governmental organizations
  • American Society for Microbiology
  • Association of Public Health Laboratories
ASIA
  • HIV: Kazakhstan, Kyrgyzstan (launched Fall 2016)
  • TB: India (launched April 2016), Vietnam (launched February 2015)
Partners: ICAP at Columbia University, CDC and local organizations CENTRAL AMERICA
  • TB: Haiti
  • Lab: Haiti

HIV ECHO program leaders in all stages of development are invited to participate in quarterly HIV MetaECHO Collaborative sessions. TB ECHO program leaders also meet quarterly in the TB MetaECHO Collaborative.

Staff

Bruce Struminger, MD

Bruce Baird Struminger, MD, MA FACP

Associate Director, Project ECHO
Associate Prof. of Medicine
HSC Div. of Infectious Diseases
BStruminger@salud.unm.edu
Karla thornton, MD

Karla Thornton, MD, MPH

Associate Director, Project ECHO
Prof. of Medicine
HSC Div. of Infectious Diseases
kthornton@salud.unm.edu
_
Michelle Iandiorio, MD

Michelle Iandiorio, MD

Medical Director, HIV ECHO
Associate Prof. of Medicine
HSC Div. of Infectious Diseases
Office: 505-272-4903
miandiorio@salud.unm.edu
Jutta Lehmer

Jutta Lehmer, BA

Program Planning Manager
Project ECHO
jlehmer@salud.unm.edu
_
Amy Armistad

Amy Armistad, MA

Program Planning Manager
Project ECHO
Office: 505-272-5811
aarmistad@salud.unm.edu
Sarah Zalud Cerrato

Sara Zalud-Cerrato

Strategic Support Manager
Project ECHO
Office: 505-925-0856 SZalud-Cerrato@salud.unm.edu